NanoViricides, Inc. (NNVC)
Develops experimental antiviral drugs using nanotech to treat viral infections like COVID and RSV.
$1.61+0.05%Healthcare
StockGlow Score
Bullish
BearishBullish
1 year ago+1.9%
The outlook
NNVC is trading at $1.61, positioned roughly midway in its 52-week range and above both its 50- and 200-day moving averages. The two analysts covering the stock both rate it a Strong Buy, with an average price target implying substantial upside versus the current level. The overall data alignment leans decidedly positive on current technicals and sentiment metrics.
What’s behind the score
Analyst consensusStrong Buy — 1.0 avg of 2 analysts
Price trendAbove its 50- & 200-day averages
52-week range55% of the way from its 52-week low to high
Price targetAvg target +273% vs current price
Market cap
$41.1M
52-wk high
$2.23
52-wk low
$0.85
50-day avg
$1.51
200-day avg
$1.30
Trailing P/E
—